ANTIPODES PARTNERS Ltd Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001652442

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q4 2023 · 71 positions · Total reported value $3.20B · Top-10 concentration 49.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.0% · 30 new · 58 cut · 16 exited

Active Share (vs S&P 500): 82.7% · vs QQQ: 84.2% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2023 13F filing, ANTIPODES PARTNERS Ltd disclosed 71 equity positions with a combined reported value of $3.20B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.5% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q4 2023 were MRK ($237.11M), ORCL ($175.35M), BIDU ($171.34M). By sector, the heaviest allocations are Technology 24.1%, Industrials 15.3%. Versus the prior quarter, allocation shifted toward Utilities (+5.1pp), Health Care (+2.4pp) and away from Technology (-1.2pp), Other (-9.7pp).

Versus the prior quarter, ANTIPODES PARTNERS Ltd opened 30 new positions, trimmed 58 and fully exited 16, a turnover rate of 65.0% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q4 2023 were GPN ($68.68M), AEM ($41.61M), INTC ($37.92M).

Of the 16 positions fully exited versus the prior quarter, the largest were SGEN ($135.15M), PAGS ($44.20M), DVMT ($43.24M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • GPN GLOBAL PMTS INC · $68.68M
  • AEM AGNICO EAGLE MINES LTD · $41.61M
  • INTC INTEL CORP · $37.92M
  • VRTX VERTEX PHARMACEUTICALS INC · $36.18M
  • ALLY ALLY FINL INC · $27.98M
  • GMAB GENMAB A/S · $5.91M
  • GM GENERAL MTRS CO · $2.51M
  • GDXJ VANECK ETF TRUST · $46.00K

Fully Exited (vs previous quarter)

  • SGEN SEAGEN INC · prev qtr: $135.15M
  • PAGS PAGSEGURO DIGITAL LTD · prev qtr: $44.20M
  • DVMT DULUTH HLDGS INC CLASS B · prev qtr: $43.24M
  • VMW VMWARE INC · prev qtr: $29.17M
  • FTCHQ FARFETCH LTD · prev qtr: $5.33M
  • EB EVENTBRITE INC · prev qtr: $108.00K
  • MP MP MATERIALS CORP · prev qtr: $70.00K
  • CZR CAESARS ENTERTAINMENT INC NE · prev qtr: $31.00K

Insider Transactions (Form 4)

Latest ANTIPODES PARTNERS Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Antipodes Partners Ltd is a Sydney, Australia-based investment firm founded by Tim Carney and Chris Murphy, known for its contrarian global equity investment strategy.

Investment Approach

Contrarian deep value strategy focusing on undervalued companies with turnaround potential.

Asset Classes

Global equities with emphasis on US markets (as evidenced by SEC 13F filings).

Key People

Founded by Tim Carney and Chris Murphy, experienced value investors with long track records.

Firm Overview

Established in 2009, Sydney-based with $14.6B AUM (per SEC Form ADV).

Official disclosures available through SEC filings.

Sector Allocation

Technology 24.1%
Industrials 15.3%
Health Care 13.8%
Financials 11.4%
Energy 5.2%
Utilities 5.1%
Other 7.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.17M $237.11M 7.41%
7.41%
Reduce
2 1.66M $175.35M 5.48%
5.48%
Reduce
3 1.44M $171.34M 5.35%
5.35%
Add
4 436.92K $164.30M 5.13%
5.13%
Reduce
5 1.99M $162.02M 5.06%
5.06%
Add
6 8.27M $149.62M 4.67%
4.67%
Add
7 2.34M $139.75M 4.37%
4.37%
Add
8 886.90K $134.76M 4.21%
4.21%
Reduce
9 609.22K $125.12M 3.91%
3.91%
Add
10 4.91M $124.48M 3.89%
3.89%
Reduce
11 17.66M $122.70M 3.83%
3.83%
Reduce
12 791.72K $103.20M 3.22%
3.22%
Reduce
13 280.07K $99.13M 3.10%
3.10%
Reduce
14 438.99K $97.70M 3.05%
3.05%
Reduce
15 1.01M $96.08M 3.00%
3.00%
Add
16 1.19M $92.41M 2.89%
2.89%
Reduce
17 1.60M $89.86M 2.81%
2.81%
Add
18 1.02M $86.71M 2.71%
2.71%
Add
19 1.90M $80.52M 2.52%
2.52%
Reduce
20 609.40K $79.91M 2.50%
2.50%
Add
21 540.77K $68.68M 2.15%
2.15%
New
22 16.67M $62.68M 1.96%
1.96%
Add
23 1.31M $53.83M 1.68%
1.68%
Reduce
24 556.72K $51.03M 1.59%
1.59%
Reduce
25 1.30M $42.97M 1.34%
1.34%
Add
26 758.63K $41.61M 1.30%
1.30%
New
27 754.58K $37.92M 1.18%
1.18%
New
28 189.14K $36.20M 1.13%
1.13%
Add
29 88.92K $36.18M 1.13%
1.13%
New
30 356.99K $29.59M 0.92%
0.92%
Reduce
31 801.13K $27.98M 0.87%
0.87%
New
32 559.55K $26.95M 0.84%
0.84%
Reduce
33 603.84K $22.37M 0.70%
0.70%
Reduce
34 5.08M $20.05M 0.63%
0.63%
Add
35 1.19M $16.44M 0.51%
0.51%
Add
36 253.86K $14.63M 0.46%
0.46%
Add
37 247.35K $14.58M 0.46%
0.46%
Hold
38 108.67K $13.90M 0.43%
0.43%
Add
39 959.35K $9.00M 0.28%
0.28%
Add
40 85.37K $7.64M 0.24%
0.24%
Hold
41 187.99K $6.77M 0.21%
0.21%
Add
42 157.95K $6.54M 0.20%
0.20%
Reduce
43 185.70K $5.91M 0.18%
0.18%
New
44 32.93K $5.34M 0.17%
0.17%
Reduce
45 317.51K $3.61M 0.11%
0.11%
Add
46 13.54K $2.75M 0.09%
0.09%
Reduce
47 69.78K $2.51M 0.08%
0.08%
New
48 29.65K $246.00K 0.01%
0.01%
Add
49 972 $231.00K 0.01%
0.01%
Reduce
50 30.08K $205.00K 0.01%
0.01%
Add

FAQ

What did ANTIPODES PARTNERS Ltd buy in 2023-Q4?

In its 2023-Q4 13F filing, ANTIPODES PARTNERS Ltd reported 71 equity positions worth $3.20B in aggregate; its largest disclosed positions were MRK ($237.11M), ORCL ($175.35M), BIDU ($171.34M).

How large is ANTIPODES PARTNERS Ltd's portfolio?

ANTIPODES PARTNERS Ltd reported $3.20B of long equity holdings across 71 positions as of 2023-Q4. Top-10 holdings account for 49.5% of reported value.

What is ANTIPODES PARTNERS Ltd's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/antipodes-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →